Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 15 (2-3) , 111-115
- https://doi.org/10.1016/j.cytogfr.2003.12.001
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Matrilysin (Matrix Metalloproteinase-7) Mediates E-Cadherin Ectodomain Shedding in Injured Lung EpitheliumThe American Journal of Pathology, 2003
- Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligandArchives of Biochemistry and Biophysics, 2002
- Protease degradomics: A new challenge for proteomicsNature Reviews Molecular Cell Biology, 2002
- Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreasJournal of Clinical Investigation, 2002
- Paneth cell trypsin is the processing enzyme for human defensin-5Nature Immunology, 2002
- Regulation of Matrilysin Expression in Airway Epithelial Cells by Pseudomonas aeruginosa FlagellinPublished by Elsevier ,2001
- Matrilysin [MMP-7] Expression Selects for Cells with Reduced Sensitivity to ApoptosisNeoplasia, 2001
- Regulation of Intestinal α-Defensin Activation by the Metalloproteinase Matrilysin in Innate Host DefenseScience, 1999
- MatrilysinPublished by Elsevier ,1998
- Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysinProceedings of the National Academy of Sciences, 1997